CAD and Aortic Stenosis in the TAVR Era: Old Questions, New Paradigms. The Evolving Role of PCI in the Treatment of Patients with Aortic Stenosis
Significant coronary artery disease (CAD) is present in up to 50% of patients with symptomatic aortic stenosis (AS). The standard treatment has been coronary artery bypass grafting at the time of surgical aortic valve replacement (AVR). While numerous databases have shown that the addition of bypass grafting to an AVR nearly doubles the mortality, surgical series have shown that leaving significant coronary stenosis untreated increases AVR mortality1-4. Thus the standard of care for this population has been concomitant coronary artery bypass grafting along with surgical aortic valve replacement. (SELECT FULL TEXT TO CONTINUE)
- Received January 16, 2012.
- Accepted January 23, 2012.
- Copyright © 2012, American Heart Association, Inc. All rights reserved. Unauthorized use prohibited